Evaxion Biotech As Stock Market Value
| EVAX Stock | USD 1.45 0.09 5.84% |
| Symbol | Evaxion |
Evaxion Biotech AS Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evaxion Biotech. If investors know Evaxion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evaxion Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share 0.713 | Return On Assets (0.69) | Return On Equity (8.03) |
The market value of Evaxion Biotech AS is measured differently than its book value, which is the value of Evaxion that is recorded on the company's balance sheet. Investors also form their own opinion of Evaxion Biotech's value that differs from its market value or its book value, called intrinsic value, which is Evaxion Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evaxion Biotech's market value can be influenced by many factors that don't directly affect Evaxion Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evaxion Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evaxion Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evaxion Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Evaxion Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Evaxion Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Evaxion Biotech.
| 12/15/2022 |
| 12/04/2024 |
If you would invest 0.00 in Evaxion Biotech on December 15, 2022 and sell it all today you would earn a total of 0.00 from holding Evaxion Biotech AS or generate 0.0% return on investment in Evaxion Biotech over 720 days. Evaxion Biotech is related to or competes with Reviva Pharmaceuticals, ZyVersa Therapeutics, Unicycive Therapeutics, Quoin Pharmaceuticals, Allarity Therapeutics, Virax Biolabs, and Biodexa Pharmaceticals. Evaxion Biotech AS, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherap... More
Evaxion Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Evaxion Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Evaxion Biotech AS upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 34.38 | |||
| Value At Risk | (7.23) | |||
| Potential Upside | 8.13 |
Evaxion Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evaxion Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Evaxion Biotech's standard deviation. In reality, there are many statistical measures that can use Evaxion Biotech historical prices to predict the future Evaxion Biotech's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.99) | |||
| Total Risk Alpha | (1.74) | |||
| Treynor Ratio | (2.70) |
Evaxion Biotech AS Backtested Returns
Evaxion Biotech AS secures Sharpe Ratio (or Efficiency) of -0.19, which denotes the company had a -0.19% return per unit of standard deviation over the last 3 months. Evaxion Biotech AS exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Evaxion Biotech's Standard Deviation of 5.76, mean deviation of 4.09, and Coefficient Of Variation of (608.38) to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.36, which means possible diversification benefits within a given portfolio. As returns on the market increase, Evaxion Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Evaxion Biotech is expected to be smaller as well. At this point, Evaxion Biotech AS has a negative expected return of -1.07%. Please make sure to confirm Evaxion Biotech's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Evaxion Biotech AS performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.72 |
Good predictability
Evaxion Biotech AS has good predictability. Overlapping area represents the amount of predictability between Evaxion Biotech time series from 15th of December 2022 to 10th of December 2023 and 10th of December 2023 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Evaxion Biotech AS price movement. The serial correlation of 0.72 indicates that around 72.0% of current Evaxion Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 2.4 |
Evaxion Biotech AS lagged returns against current returns
Autocorrelation, which is Evaxion Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Evaxion Biotech's stock expected returns. We can calculate the autocorrelation of Evaxion Biotech returns to help us make a trade decision. For example, suppose you find that Evaxion Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Evaxion Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Evaxion Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Evaxion Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Evaxion Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Evaxion Biotech Lagged Returns
When evaluating Evaxion Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Evaxion Biotech stock have on its future price. Evaxion Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Evaxion Biotech autocorrelation shows the relationship between Evaxion Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Evaxion Biotech AS.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.